Back to
TRUIST FINANCIAL CORP
ONCY1 quarters
Position history for
TRUIST FINANCIAL CORP's holdings in ONCOLYTICS BIOTECH INC
Yes. Truist Financial holds 20,000 shares of ONCY (Oncolytics Biotech), worth $19,000, as of its Q2 2026 13F filing.
Current Value
$19,000
Current Shares
20,000
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ONCY: MARSHALL WACE, LLP, XTX Topco Ltd, GOLDMAN SACHS GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP